Often when demonstrating the Acuity platform or presenting our capabilities, we are asked this question: How can Acuity help us in reducing cost and improving quality? I ask them in return: does your car help you transport from one place to another? The answer is of course yes, that is what the car is supposed to do, but it cannot do it alone; someone must drive the car to reach the intended destination. Likewise, Acuity can help in spotting trends, outliers and patterns but the work does not stop there. The organization must have practices in place to review these visualizations on a regular basis and interact with site investigators and senior management to arrive at meaningful conclusions that drive actions. Unless these results are also tied to time sensitive agreements, these visualizations will continue to show red when things don’t change. Analytics can help mine data and forecast/predict future patterns but this intelligence must be applied to actions. Our experience with existing customers suggested that effective action was a significant challenge. This led us to develop our centralized monitoring offering – a service which enables trained clinical research associates to perform regular review of visualizations and converting the observations into actions in our action center thus enabling the continuum of the data value chain translating data to insights and decisions to actions.
So back to the initial question, can a car help you go from one destination to another? Yes if, and only if, you know how to drive it or you have a chauffeur who can take you where you need to go. Similarly, Algorics provides you Acuity as the data analytics platform to enable you make the right decisions. If you are running short of people who can interpret these data visualizations and summarize actions, then we also provide a value added service of centralized monitoring resources to help you drive insights to action recommendations that your team needs to take in order to ensure subject safety, improve data quality and eventually drive down operating costs. The reduction in cost of quality is huge compared to the cost of saving a few monitoring visits and above all it brings continuous vigilance to subject safety monitoring which is crucial to the success of a drug or device seeking approval.